deferiprone has been researched along with Cerebral Malaria in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordeuk, VR | 1 |
| Loyevsky, M | 1 |
| Mohanty, D | 1 |
1 review available for deferiprone and Cerebral Malaria
| Article | Year |
|---|---|
Antimalarial effect of iron chelators.
Topics: Animals; Antimalarials; Child; Deferiprone; Deferoxamine; Drug Therapy, Combination; Humans; In Vitr | 2002 |
1 other study available for deferiprone and Cerebral Malaria
| Article | Year |
|---|---|
Red cell adhesion in cerebral malaria.
Topics: Animals; Cell Adhesion; Deferiprone; Erythrocytes; Humans; Malaria, Cerebral; Malaria, Falciparum; P | 2007 |